Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss

Journal of Reproductive Immunology

Volumn 85, Issue 2, 2010, Pages 186-192

  Obayashi, Shintaro ^a   Ozaki, Yasuhiko ^a   Sugi, Toshitaka ^b   Kitaori, Tamao ^a   Katano, Kinue ^a   Suzuki, Sadao ^a   Sugiura Ogasawara, Mayumi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Laboratory for Recurrent Pregnancy Loss   (Japan)

Author keywords

2 glycoprotein I dependent anticardiolipin antibody; Antiphosphatidylethanolamine antibody; Lupus anticoagulant; Recurrent pregnancy loss

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE ANTIBODY; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLETHANOLAMINES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN BINDING; RISK FACTORS;

EID: 77953616193     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.03.002     Document Type: Article

References (24)

1. Bever E.M., Galli M., Barbui T., Comfurius P., Zwaal R.F.A. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 1991, 66:629-632.
2. Brandt J.T. Assays for phospholipid-dependent formation of thrombin and Xa: a potential method for quantifying lupus anticoagulant activity. Thromb. Haemost. 1991, 66:453-458.
3. Farquharson R.G., Pearson J.F., John L. Lupus anticoagulant and pregnancy management. Lancet 1984, 28:228-229.
4. Gris J.C., Quéré I., Sanmarco M., Boutiere B., Mercier E., Amiral J., Hubert A.M., Ripart-Neveu S., Hoffet M., Tailland M.L., Rousseau O., Monpeyroux F., Dauzat M., Sampol J., Daures J.P., Berlan J., Marès P. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA. Thromb. Haemost. 2000, 84:228-236.
5. Katano K., Aoki A., Sasa H., Ogasawara M., Matsuura E., Yagami Y. Beta 2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum. Reprod. 1996, 11:509-512.
6. Katano K., Aoki K., Ogasawara M.S., Suzumori K. Adverse influence of numbers of previous miscarriages on results of paternal lymphocyte immunization in patients with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 2000, 44:289-292.
7. Kenny L.C., Baker P.N., Kendall D.A., Randall M.D., Dunn W.R. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin. Sci. 2002, 103:67-73.
8. Matsubayashi H., Arai T., Izumi S., Sugi T., McIntyre J.A., Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil. Steril. 2001, 76:694-699.
9. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa I., Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990, 21:177-178.
10. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 1994, 179:457-462.
11. Miyakis S., Robertson S.A., Krillis S.A. Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice. Clin. Immunol. 2004, 112:136-143.
12. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H.W.M., De Groot P.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., Krilis S.A. International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006, 4:295-306.
13. Ogasawara M., Aoki K., Matsuura E., Sasa H., Yagami Y. Anti β2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Lupus 1996, 5:587-592.
14. Ogasawara M., Aoki K., Kajiura S., Yagami Y. Are antinuclear antibodies predictive of recurrent miscarriage?. Lancet 1996, 347:1183-1184.
15. Ogasawara M., Aoki K., Katano K., Ozaki Y., Suzumori K. Factor XII but not protein C, protein S, antithrombin III or factor XIII as a predictor of recurrent miscarriage. Fertil. Steril. 2001, 75:916-919.
16. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-257.
17. Roubey R.A.S., Pratt C.W., Buyon J.P., Winfield J.B. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2glycoprotein I. J. Clin. Invest. 1992, 90:1100-1104.
18. Roubey R.A.S. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulant and other " antiphospholipid" autoantibodies. Blood 1994, 84:2854-2867.
19. Sugi T., McIntyre J.A. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995, 86:3083-3089.
20. Sugi T., Katsunuma J., Izumi S., McIntyre J.A., Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil. Steril. 1999, 71:1060-1065.
21. Sugiura-Ogasawara M., Ozaki Y., Sato T., Suzumori N., Suzumori K. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil. Steril. 2004, 81:367-373.
22. Sugiura-Ogasawara M., Ozaki Y., Kitaori T., Kumagai K., Suzuki S. Midline uterine defect size correlated with miscarriage of euploid embryos in recurrent cases. Fertil. Steril. 2010, 93:1983-1988.
23. Yamada H., Atsumi T., Kobashi G., Ota C., Kato E.H., Tsuruga N., Ohta K., Yasuda S., Koike T., Minakami H. Antiphospholipid antibodies increase the risk of pregnancy induced hypertension and adverse pregnancy outcomes. J. Reprod. Immunol. 2009, 79:188-195.
24. Vonnahme K.A., Fernando S.C., Ross J.W., Ashworth M.D., DeSilva U., Malayer J.R., Geisert R.D. Porcine endometrial expression of kininogen, factor XII, and plasma kallikrein in cyclic and pregnant gilts. Biol. Reprod. 2004, 70:132-138.